<DOC>
	<DOCNO>NCT02948790</DOCNO>
	<brief_summary>The aim study assess auditory nerve functionality intraoperative approach follow surgical removal acoustic neuroma patient severe profound sensorineural hearing disability .</brief_summary>
	<brief_title>Auditory Nerve Monitoring Using Intra-cochlear Stimulation Subjects With Acoustic Neuroma</brief_title>
	<detailed_description>Whatever acoustic neuroma treatment , patient risk hear loss . The global strategy hear care aim preserve quality life patient hearing . For severe profound hearing loss anatomical auditory nerve preservation , cochlear implant put forward compare auditory brainstem implant . Indeed , cochlear implant provide well speech outcomes . If cochlear implantation possible benefit patient , brainstem implant widely use . The Neuristim device use investigate auditory nerve integrity follow neuroma surgery affect auditory nerve . The Neuristim intra-cochlear stimulator use intraoperative way . The intra-cochlear electrode provide electrical stimulation auditory nerve fiber , auditory nerve response measurement electrical stimulation record evaluated determine auditory nerve functionality . The Neuristim device help surgeon choose appropriate implantable solution . 2 group patient involve study : - group 17 patient acoustic neuroma past neuroma surgically remove acoustic neuroma require surgery severe profound hear loss candidate cochlear implant auditory brainstem depend auditory nerve functionality , - group 17 patient severe profound hearing loss candidate cochlear implant .</detailed_description>
	<mesh_term>Hearing Loss</mesh_term>
	<mesh_term>Neuroma</mesh_term>
	<mesh_term>Neuroma , Acoustic</mesh_term>
	<mesh_term>Hearing Loss , Sensorineural</mesh_term>
	<criteria>Must 18 year old Patient acoustic neuroma already surgically remove associate hearing loss ( experimental group ) , Patient acoustic neuroma program surgically remove candidate implantable hear rehabilitation solution ( experimental group ) , Patient acoustic neuroma need remove candidate implantable hearing rehabilitation solution ( experimental group ) , Typical patient candidate cochlear implant ( control group ) Cochlea malformation , cochlea ossification Vulnerable subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>